These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 20359598)
1. Adenylyl cyclase 6 deletion reduces left ventricular hypertrophy, dilation, dysfunction, and fibrosis in pressure-overloaded female mice. Tang T; Lai NC; Hammond HK; Roth DM; Yang Y; Guo T; Gao MH J Am Coll Cardiol; 2010 Apr; 55(14):1476-86. PubMed ID: 20359598 [TBL] [Abstract][Full Text] [Related]
2. Activated expression of cardiac adenylyl cyclase 6 reduces dilation and dysfunction of the pressure-overloaded heart. Sugano Y; Lai NC; Gao MH; Firth AL; Yuan JX; Lew WY; Hammond HK Biochem Biophys Res Commun; 2011 Feb; 405(3):349-55. PubMed ID: 21195051 [TBL] [Abstract][Full Text] [Related]
3. Effects of cardiac overexpression of type 6 adenylyl cyclase affects on the response to chronic pressure overload. Guellich A; Gao S; Hong C; Yan L; Wagner TE; Dhar SK; Ghaleh B; Hittinger L; Iwatsubo K; Ishikawa Y; Vatner SF; Vatner DE Am J Physiol Heart Circ Physiol; 2010 Sep; 299(3):H707-12. PubMed ID: 20562336 [TBL] [Abstract][Full Text] [Related]
4. Cardiac-Directed Expression of Adenylyl Cyclase Catalytic Domain ( Tan Z; Giamouridis D; Lai NC; Kim YC; Guo T; Xia B; Gao MH; Hammond HK Hum Gene Ther; 2019 Jun; 30(6):682-692. PubMed ID: 30638074 [TBL] [Abstract][Full Text] [Related]
5. Adenylyl cyclase 6 improves calcium uptake and left ventricular function in aged hearts. Tang T; Hammond HK; Firth A; Yang Y; Gao MH; Yuan JX; Lai NC J Am Coll Cardiol; 2011 May; 57(18):1846-55. PubMed ID: 21527160 [TBL] [Abstract][Full Text] [Related]
6. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery. Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510 [TBL] [Abstract][Full Text] [Related]
7. Adenosine A3 receptor deficiency exerts unanticipated protective effects on the pressure-overloaded left ventricle. Lu Z; Fassett J; Xu X; Hu X; Zhu G; French J; Zhang P; Schnermann J; Bache RJ; Chen Y Circulation; 2008 Oct; 118(17):1713-21. PubMed ID: 18838560 [TBL] [Abstract][Full Text] [Related]
8. AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice. Zhang P; Hu X; Xu X; Fassett J; Zhu G; Viollet B; Xu W; Wiczer B; Bernlohr DA; Bache RJ; Chen Y Hypertension; 2008 Nov; 52(5):918-24. PubMed ID: 18838626 [TBL] [Abstract][Full Text] [Related]
9. Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction. Zhao L; Cheng G; Jin R; Afzal MR; Samanta A; Xuan YT; Girgis M; Elias HK; Zhu Y; Davani A; Yang Y; Chen X; Ye S; Wang OL; Chen L; Hauptman J; Vincent RJ; Dawn B Circ Res; 2016 Jun; 118(12):1918-1929. PubMed ID: 27126808 [TBL] [Abstract][Full Text] [Related]
10. MK5 haplodeficiency attenuates hypertrophy and preserves diastolic function during remodeling induced by chronic pressure overload in the mouse heart. Nawaito SA; Dingar D; Sahadevan P; Hussein B; Sahmi F; Shi Y; Gillis MA; Gaestel M; Tardif JC; Allen BG Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H46-H58. PubMed ID: 28432058 [TBL] [Abstract][Full Text] [Related]
11. Pregnancy mitigates cardiac pathology in a mouse model of left ventricular pressure overload. Xu H; van Deel ED; Johnson MR; Opić P; Herbert BR; Moltzer E; Sooranna SR; van Beusekom H; Zang WF; Duncker DJ; Roos-Hesselink JW Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H807-14. PubMed ID: 27371681 [TBL] [Abstract][Full Text] [Related]
14. Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction. Xu X; Fassett J; Hu X; Zhu G; Lu Z; Li Y; Schnermann J; Bache RJ; Chen Y Hypertension; 2008 Jun; 51(6):1557-64. PubMed ID: 18391093 [TBL] [Abstract][Full Text] [Related]
15. Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling. Tang T; Gao MH; Lai NC; Firth AL; Takahashi T; Guo T; Yuan JX; Roth DM; Hammond HK Circulation; 2008 Jan; 117(1):61-9. PubMed ID: 18071070 [TBL] [Abstract][Full Text] [Related]
16. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction. Xu X; Zhang P; Kwak D; Fassett J; Yue W; Atzler D; Hu X; Liu X; Wang H; Lu Z; Guo H; Schwedhelm E; Böger RH; Chen P; Chen Y Basic Res Cardiol; 2017 Aug; 112(5):55. PubMed ID: 28819685 [TBL] [Abstract][Full Text] [Related]
18. AT1 blockade abolishes left ventricular hypertrophy in heterozygous cMyBP-C null mice: role of FHL1. Vignier N; Le Corvoisier P; Blard C; Sambin L; Azibani F; Schlossarek S; Delcayre C; Carrier L; Hittinger L; Su JB Fundam Clin Pharmacol; 2014 Jun; 28(3):249-56. PubMed ID: 23600722 [TBL] [Abstract][Full Text] [Related]
19. Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice. Gogiraju R; Schroeter MR; Bochenek ML; Hubert A; Münzel T; Hasenfuss G; Schäfer K Cardiovasc Res; 2016 Aug; 111(3):204-16. PubMed ID: 27207947 [TBL] [Abstract][Full Text] [Related]
20. Role of HSF1-upregulated AC6 in ameliorating heart failure in mice. The E; Du P; Chang Y; Dai F; Wei C; Li J Environ Toxicol Pharmacol; 2016 Oct; 47():79-85. PubMed ID: 27643574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]